Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 5 Immunoblot analysis of caspase-3 and its cleavage substrates gelsolin and fodrin in the left ventricles of patients with end-stage heart failure, as compared with donor hearts: 17- and 19-kDa–cleaved caspase-3 was exclusively detectable in cell lysates from cytochrome c–treated Jurkat and NIH 3T3 cell extracts. Neither donor hearts nor terminally failing hearts revealed caspase-3 activation when using an anti-active caspase-3 antibody (Cell Signaling Technology) (a). When performing an immunoblot with an antibody against the 32-kDa inactive and active caspase-3 proteins (Pharmingen), there was no cleavage product detectable, although procaspase-3 was detectable in a similar amount (b). For gelsolin, we found only the uncleaved form in both groups (c). The terminally failing hearts revealed significantly more cleaved (p < 0.001) and uncleaved (p < 0.05) fodrin, as compared with donor hearts (d). Equal protein loading of each patient has been shown by coomassie staining (e).





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement